Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06892249
NA
Suitability of a High-energy, Low-protein Formula (Renalive® LP)
Sponsor: Fresenius Kabi Taiwan Ltd.
View on ClinicalTrials.gov
Summary
Inclusion criteria (1) Diagnosed with chronic kidney disease stage 3b-5 (with history of eGFR\<45 mL/min/1.73 m2) Exclusion criteria (1) Has received dialysis or are expected to start dialysis within the next 3 months.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2025-06-04
Completion Date
2027-12-31
Last Updated
2026-10-01
Healthy Volunteers
No
Interventions
DIETARY_SUPPLEMENT
Renalive® LP,
flavour
Locations (2)
Kaosiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan
Taipei TzuChi Hospital
New Taipei City, Taiwan